BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society of Cannabis Clinicians - ECPv6.15.15//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Society of Cannabis Clinicians
X-ORIGINAL-URL:https://www.cannabisclinicians.org
X-WR-CALDESC:Events for Society of Cannabis Clinicians
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20210403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20211002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20220402T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20221001T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Bogota
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230315T090000
DTEND;TZID=America/Los_Angeles:20230315T170000
DTSTAMP:20260603T233316
CREATED:20230315T132444Z
LAST-MODIFIED:20230316T105123Z
UID:10000131-1678870800-1678899600@www.cannabisclinicians.org
SUMMARY:SCC and Csequence Journal Club Presents: CBD & the Brain with Jong Rho\, MD
DESCRIPTION:This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nThis month’s installment will hear Dr. Jong Rho discuss his research on how “Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity.” \nJong M. Rho\, MD \nDr. Rho is a Professor of Neurosciences\, Pediatrics and Pharmacology at the University of California\, San Diego\, and Division Chief of Pediatric Neurology at the Rady Children’s Hospital San Diego. He received an undergraduate degree in molecular biophysics and biochemistry at Yale University\, and an M.D. from the University of Cincinnati. Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital\, the University of California at Irvine\, the Barrow Neurological Institute (Phoenix)\, University of Arizona and Arizona State University\, and most recently\, the University of Calgary and the Alberta Children’s Hospital. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet. His research activities have been sponsored by research grants from the U.S. National Institutes of Health\, Canadian Institutes of Health Research\, Brain Canada\, and a variety of intramural and extramural public and private sector sources. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-and-csequence-journal-club-presents-cbd-the-brain-with-jong-rho-md/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/03/MJC-March-15-2023-with-Dr.-Jong-Rho-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230217T090000
DTEND;TZID=America/Los_Angeles:20230217T100000
DTSTAMP:20260603T233316
CREATED:20221101T150006Z
LAST-MODIFIED:20230124T164007Z
UID:10000128-1676624400-1676628000@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: Featuring Igor Grant\, MD\, FRCP(C)
DESCRIPTION:Description\nIgor Grant\, M.D.\, F.R.C.P. (C) \nDistinguished Professor\, UC San Diego\, Department of Psychiatry \nDirector\, Center for Medicinal Cannabis Research \nDr. Igor Grant is Distinguished Professor and director of the HIV Neurobehavioral Research Program and the Center for Medicinal Cannabis Research at the University of California San Diego (UCSD). Dr. Grant served as Chair of the UCSD Department of Psychiatry from 2014-2019. He is a neuropsychiatrist who graduated from the University of British Columbia School of Medicine (1966)\, and received specialty training in psychiatry at the University of Pennsylvania (1967-1971)\, and additional training in neurology at the Institute of Neurology (Queen Square) (1980-1981)\, London\, U.K. Dr. Grant’s academic interests focus on the effects of various diseases on brain and behavior\, with an emphasis on translational studies in HIV\, and drugs of abuse. He has contributed to approximately 800 scholarly publications and is principal investigator of several NIH studies. \nSince 2000\, Dr. Grant has been Director of the State of California funded Center for Medicinal Cannabis Research (CMCR). The Center was funded following passage of California Prop 215\, the “Compassionate Use Act” which envisioned providing patients under doctor supervision with access to medicinal cannabis in patients whose condition warranted it. California established the CMCR to develop a knowledge base concerning cannabis. \nHeadquartered at the University of California San Diego (UCSD)\, the Center has completed several studies on medical cannabis in relation to neuropathic pain and muscle spasticity in Multiple Sclerosis\, as well as cannabis and driving impairment. Results of the studies have been published in the scientific literature and are available at: http://www.cmcr.ucsd.edu/\, many found evidence of at least short term benefit of medicinal cannabis. \nCurrently the CMCR is conducting a number of studies on both therapeutic potentials (e.g.\, with pain\, autism\, anxiety\, metabolic syndrome\, and diabetes) and potential risks (e.g.\, automobile driving) of medicinal cannabis. Studies are beginning to explore modes of administration and specific cannabinoids (e.g.\, THC\, CBD). \nCMCR has been the source of authoritative information that is developing on medicinal cannabis and has consulted with the Legislature of the State of California\, the Office of the Lieutenant Governor of California (Blue Ribbon Commission’s Regulatory & Tax Structure Working Group)\, and contributed to the recent National Academies report\, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research” (2017). \nRegister
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-featuring-igor-grant-md-frcpc/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/11/Quarterly-Meeting-with-Igor-Grant-Feb-2023.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230204T090000
DTEND;TZID=America/Los_Angeles:20230205T180000
DTSTAMP:20260603T233316
CREATED:20230123T155937Z
LAST-MODIFIED:20230124T163742Z
UID:10000130-1675501200-1675620000@www.cannabisclinicians.org
SUMMARY:Natural Healing Hawaii - A naturopathic lifestyle EXPO
DESCRIPTION:The natural medicine focused expo is a great opportunity for healthcare professionals to collaborate together and discuss current issues\, receive educational information\, and dialogue on key issues like the Dual Use of Cannabis Task Force panel discussion which includes Ryan’s Law. \nWhile there you can also buy some of the best medical cannabis books and informative material. Please bring strong shopping bags! Hope to see you there! \nRegister
URL:https://www.cannabisclinicians.org/event/natural-healing-hawaii-a-naturopathic-lifestyle-expo/
LOCATION:Blaisdell Exhibition Hall
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2023/01/cannabis_flyer_poster_for_wendy.001.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230111T090000
DTEND;TZID=America/Los_Angeles:20230111T100000
DTSTAMP:20260603T233316
CREATED:20221012T162529Z
LAST-MODIFIED:20221104T143004Z
UID:10000112-1673427600-1673431200@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Farzana Kennedy\, RPh\, BSPharm\, FACA
DESCRIPTION:Join us for “Canna Talk: Pharmacy Edition” on January 11th as we hear from our special guest Farzana Kennedy\, RPh\, BSPharm\, FACA. Dr. Kennedy will discuss her background\, how she became involved in cannabis medicine\, and answer pertinent questions related to her course module on Cannabis and Policy: Impacts on the Healthcare Environment as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.” \nThis educational webinar series is free for all to attend. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers:\nFarzana Kennedy\nAlan Ao\nBobby Vincent \nSpeaker bio:\nFarzana Kennedy\, RPh\, BSPharm\, FACA\, is the owner\, president\, and director of clinical operations of NewLeaf\, a West Virginia medical cannabis operator. She is a founding member and past president and pharmacist in charge of Dalitso LLC in Virginia where she managed all cultivation\, processing\, and dispensary functions. \nAs a founding board member and the inaugural president of the Virginia Medical Cannabis Coalition (VMCC) Farzana worked to establish and expand Virginia’s medical cannabis program by being involved in the regulatory and legislative process. She is also the chair of the Virginia Pharmacist Association (VPhA) Academy of Medical Cannabis and provides Virginia pharmacists with cannabis industry training and education. \nFarzana has over twenty-five years of compounding and clinical pharmacy experience\, most notably as the former owner and president of Alexandria Compounding Pharmacy. She is an appointee to the Northern Virginia Regional Human Rights Committee (NVRHRC) and is currently working with Virginia Department of Behavioral Health and Developmental Services as a COVID-19 clinical pharmacist consultant for the mental health and substance use disorder population. \nFarzana received her pharmacy degree from Howard University School of Pharmacy. She is a 2023 MS candidate at the University of Maryland Baltimore Graduate School Medical Cannabis Science and Therapeutics program and is a member of several professional pharmacy and cannabis organizations.
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-farzana-kennedy-rph-bspharm-faca/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/10/MHSGcLEQ6YrmSSZGd.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221207T090000
DTEND;TZID=America/Los_Angeles:20221207T220000
DTSTAMP:20260603T233316
CREATED:20221012T160936Z
LAST-MODIFIED:20221104T142906Z
UID:10000111-1670403600-1670450400@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Codi Peterson\, PharmD\, MS
DESCRIPTION:Join us for “Canna Talk: Pharmacy Edition” on December 7th as we hear from our special guest Codi Peterson\, PharmD\, MS. Dr. Peterson will discuss his background\, how he became involved in cannabis medicine\, and give the insider view on the two courses he developed as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.” This educational webinar series is free for all to attend. \nCannabis: A Rich History Clouded in Stigma\nThe journey of cannabis through the millennia is woven between stories of agriculture\, medicine\, spirituality\, and recreation. The pathway to modern-day reformation requires an understanding of how political agendas shaped cannabis into the polarizing topic it is today. This course addresses cannabis prohibition and how the subsequent War on Drugs has disproportionately affected BIPOC communities. Course participants will learn how the stigmatization of cannabis and its consumption continues to exist today as a multifaceted issue. \nThe Future of Cannabis Medicine\nThe future of cannabis and cannabinoid-based medicine is riddled with competing interests and powerhouse industries. Prohibition has led to difficulties studying the cannabis plant on both a molecular level as well as large scale clinical trials. The endocannabinoidome is an expanded scope of what science currently knows and the questions that still need to be resolved as we move forward. The future implications of this knowledge are boundless and have the potential to significantly influence our approach to medical practices. Course participants will gain an understanding of the relationship between varying cannabinoid activity and the endocannabinoid system (ECS)\, become familiar with the expanded scope of the endocannabinoidome (eCBome)\, and much more. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers\nBobby Vincent\nAlan Ao\nCodi Peterson \nSpeaker bio:\nDr. Codi Peterson is a pediatric pharmacist and cannabis science expert. Leveraging a decade of clinical pharmacy experience\, Codi strives to bridge the gap between healthcare and cannabis through education and advocacy. He is PharmD graduate from Duquesne University and later graduated with an MS in Medical Cannabis Science & Therapeutics. Codi is the Chief Science Officer of The Cannigma\, a science forward media company who wants to help the world get cannabis. Dr. Peterson is also an educator for OCEMT where he teaches pharmacology to paramedics in southern California. Codi is co-founder of the Pharmacists Cannabis Coalition of California (PCCC)\, a public-benefit nonprofit dedicated to educating and elevating California pharmacists in the cannabis space. Additionally Codi is an advisor to numerous companies in the cannabis industry\, including Hembel and the Cannabis Spa Association. He believes that cannabis is medicine and patients deserve access to medicine\, which includes the right to speak with a healthcare professional.
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-codi-peterson-pharmd-ms/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/10/Zr7wcYxpYrqDY4Ro2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221116T090000
DTEND;TZID=America/Los_Angeles:20221116T100000
DTSTAMP:20260603T233316
CREATED:20221012T153538Z
LAST-MODIFIED:20221103T200555Z
UID:10000110-1668589200-1668592800@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Michael Ruggiero\, PharmD\, AAHIVP
DESCRIPTION:Join us for “Canna Talk: Pharmacy Edition” on November 16th as we explore The Cannabis Pharmacist: A Bottom-up Clinical Approach with Michael Ruggiero\, PharmD\, AAHIVP. Dr. Ruggerio will discuss his background\, how he became involved in cannabis medicine\, and provide a glimpse into the material covered in his course. This course addresses the primary differences between the medical cannabis industry and traditional pharmaceuticals\, teaches participants how to confidently develop tailor-made dosing protocols for patients\, and how to comprehend the nuances of various dosage forms and ROAs for cannabinoid-based products\, along with much more. If you are interested in taking the course beforehand so that you can ask your questions live\, you can purchase the course here. \nThis educational webinar series is free for all to attend. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers:\nAlan Ao\nBobby Vincent\nMichael Ruggiero \nSpeaker Bio: \nDr. Michael Ruggiero is the Regional Pharmacy Manager for Beyond / Hello in Pennsylvania. Prior to entering the Cannabis Industry he worked as a community pharmacist with certifications in medication therapy management\, HIV\, and cannabis. Since beginning to work in the industry he has given educational presentations on cannabis to healthcare and non-healthcare professionals alike\, spoke on a podcast for Cannigma\, provided Veteran driven education\, created knowledge assessments for his team\, developed oral product formulation dosing charts for the products at his dispensary\, and currently is Vice President of International Society of Cannabis Pharmacists. In addition he teaches HIV pharmacotherapeutics to Physician Assistant students at Thomas Jefferson University.
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-michael-ruggiero-pharmd-aahivp/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/10/DZZJzu4YHqDsR2XWq.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221012T213000
DTEND;TZID=America/Los_Angeles:20221012T223000
DTSTAMP:20260603T233316
CREATED:20220921T170340Z
LAST-MODIFIED:20220922T123824Z
UID:10000109-1665610200-1665613800@www.cannabisclinicians.org
SUMMARY:Canna Talk: Pharmacy Edition -- Featuring Curriculum Co-Directors
DESCRIPTION:Don’t miss the kickoff event “Canna Talk: Pharmacy Edition” on October 12th as we explore the course material that is covered in the new curriculum: Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry. \nThis educational webinar series is free for all to attend. The curriculum co-directors Alan Ao\, PharmD and Bobby Vincent\, III\, PharmD\, RPh will share a brief overview of what course participants can expect to learn after completing this curriculum and will also delve deeper into the specific topics that Dr. Alan Ao covers in his module The Cannabis Pharmacist: A Bottom-up Clinical Approach. Learn more in their bios below. \nEstablished cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above. \nSpeakers:\nAlan Ao\, PharmD\, Bobby Vincent \nAlan Ao\, PharmD\nDr. Alan Ao is a registered pharmacist and lifelong NJ native. With over 20 years of retail experience\, the majority of his professional career has been spent working alongside patients in independent retail settings specializing in patient care counseling\, prescription drug compounding\, and alternative medicine. Dr. Ao served as Vice President/Clinical Pharmacist in one of New Jersey’s first vertically integrated alternative treatment centers for 2.5 years before launching his own consulting firm. He’s the Founder and President of Plants and Prescriptions – a consulting firm developing an industry where cannabis and modern-day healthcare collide through education and advocacy. He currently serves as an advisory board member for the Association of Cannabis Health Equity and Medicine and pharmacy course director for the Society of Cannabis Clinicians. Dr. Ao is also involved as a course instructor for dispensary operations for both NJ Cannabis Certified and the Minority Cannabis Academy. \nBobby Vincent\, III\, PharmD\, RPh\nBobby Vincent\, III\, PharmD\, RPh is a Clinical Cannabinoid Pharmacotherapist born and raised in Richmond\, Virginia. Dr. Vincent is driven by a passion to bridge the medical cannabis industry with communities in need. Dr. Vincent currently serves the northern Virginia and Washington\, D.C. metropolitan area as a pharmacist and medical consult– providing care for hundreds of cannabis patients. Dr. Vincent is the founder of Cannabis Health Alliances\, LLC.\, building partnerships to advance therapy\, policy and patient accessibility. He also serves as the Communications Chair for the Virginia Pharmacists Association Academy of Medical Cannabis and a member of the organization’s Task Force for Racial Diversity\, Equity\, and Inclusion. \nDr. Vincent is a graduate of Hampton University where he obtained a Doctor of Pharmacy degree. He recently earned his Masters of Cannabis Science and Therapeutics Degree at the University of Maryland\, Baltimore – the first degree of its kind available in the United States. He has experienced a host of unique learning opportunities\, including time abroad in Thailand\, United Arab Emirates\, and the Philippines as a medical volunteer. Dr. Vincent also spent time with the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Office of Science Policy and Communications as a pharmacy intern. \nTo join as a listener\, enter code 856348569 \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/canna-talk-pharmacy-edition-featuring-curriculum-co-directors/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/09/SCC-CannaTalk-Pharmacy-Edition-Oct-12-22-post.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221007T090000
DTEND;TZID=America/Los_Angeles:20221007T100000
DTSTAMP:20260603T233316
CREATED:20220804T143249Z
LAST-MODIFIED:20220804T174921Z
UID:10000108-1665133200-1665136800@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club – Dr. Thomas Marcotte\, The Complex Relationship Between Cannabis and Driving
DESCRIPTION:Speaker:\nThomas Marcotte\, PhD \nArticle: \nDriving Performance and Cannabis Users’ Perception of Safety: A Randomized Clinical Trial \nMeet Dr. Thomas Marcotte: \nDr. Thomas Marcotte is Professor of Psychiatry at the University of California\, San Diego\, and Co-Director of the Center for Medicinal Cannabis Research\, which has conducted clinical trials of cannabis for over 20 years and has an active\, ongoing portfolio exploring the effects of cannabinoids (plant-based\, synthetic) in various medical/psychiatric conditions. He is the principal investigator on studies addressing the effects that cannabis has on driving performance\, including in combination with alcohol\, as well as methods for detecting cannabis-related driving impairment. He is currently a principal investigator on a study examining cannabis for the treatment of sports-related injuries in elite athletes\, and previously was the principal investigator on an NIH-funded take-home study of cannabis for the treatment of pain\, and a co-investigator on cannabis studies addressing pain\, as well spasticity in multiple sclerosis. Dr. Marcotte has served on the editorial boards of Neuropsychology and the Journal of the International Neuropsychological Society\, was co-chair of the Research\, Data and Technology subcommittee of the State of California Impaired Driving Task Force\, and a member on the California Office on Traffic Safety Impaired Driving Blueprint Roundtable. He is co-editor of the book Neuropsychology of Everyday Functioning\, 2nd Edition (Marcotte\, Schmitter-Edgecombe & Grant) \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/csequence-scc-journal-club-thomas-marcotte-driving-performance-and-cannabis-users-perception-of-safety-a-randomized-clinical-trial/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/08/MJC-Oct-7-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220907T090000
DTEND;TZID=America/Los_Angeles:20220907T100000
DTSTAMP:20260603T233316
CREATED:20220804T141839Z
LAST-MODIFIED:20220805T100514Z
UID:10000107-1662541200-1662544800@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club - Dr. Ran Abuhasira\, Cannabis is associated with Blood Pressure Reduction in Older Adults
DESCRIPTION:September 7\, 2022 \nSpeaker: \nRan Abuhasira\, MD PhD\, \nArticle: \nCannabis is Associated with Blood Pressure Reduction in Older Adults: A 24-hour ambulatory blood pressure monitoring study \nMeet Dr. Ran Abuhasira \nDepartment of Internal Medicine B\, Rabin Medical Center\, Beilinson Campus. \nDr. Abuhasira completed his PhD at the Cannabis Clinical Research Institute (CCRI) under the supervision of Prof. Victor Novack. The CCRI is part of the Clinical Research Center at Soroka University Medical Center in Beer-Sheva\, Israel. His study focused on assessing the safety and efficacy of medical cannabis in the elderly population. His work was published in a number of papers and presented in scientific conferences worldwide. \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dr-ran-abuhasira-cannabis-is-associated-with-blood-pressure-reduction-in-older-adults/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/08/MJC-Sept-7-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220902T080000
DTEND;TZID=America/Los_Angeles:20220903T170000
DTSTAMP:20260603T233316
CREATED:20220804T120908Z
LAST-MODIFIED:20220805T101725Z
UID:10000106-1662105600-1662224400@www.cannabisclinicians.org
SUMMARY:First International Congress on Medical Use of Cannabis and Entheogens
DESCRIPTION:Tuesday\, September 2\, 2022 – Wednesday\, September 3\, 2022 \nEvent Description \nAn academic conference with a clear objective\, to bring together cannabis and entheogen experts to present scientific evidence and experience from their role in science and society; following the principles of ethics\, empathy and with the human vision of medicine\, for Peru and the world.
URL:https://www.cannabisclinicians.org/event/first-international-congress-on-medical-use-of-cannabis-and-entheogens/
LOCATION:Lima\, Peru
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2022/08/FLYER_CONGRESS_INGLES.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220701T090000
DTEND;TZID=America/Los_Angeles:20220701T103000
DTSTAMP:20260603T233316
CREATED:20220525T052110Z
LAST-MODIFIED:20220628T043637Z
UID:10000105-1656666000-1656671400@www.cannabisclinicians.org
SUMMARY:CSequence & The Society of Cannabis Clinicians Presents Journal Club: Cannabis vs. Opioids For Back Pain- Two New Studies
DESCRIPTION:The Society of Cannabis Clinicians Journal Club Featuring Dr. Dustin Sulak \nFriday\, July 1\, 2022 \nEvent Description\n\nJoin us for the upcoming SCC Journal Club featuring Dr. Dustin Sulak as he shares his presentation on “Cannabis vs. Opioids For Back Pain: Two New Studies!” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC members\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nMeet Dr. Dustin Sulak: \nDr. Dustin Sulak \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/csequence-the-society-of-cannabis-clinicians-presents-journal-club-cannabis-vs-opioids-for-back-pain-two-new-studies/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/05/2.jpeg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220624T090000
DTEND;TZID=America/Los_Angeles:20220624T103000
DTSTAMP:20260603T233316
CREATED:20220503T173820Z
LAST-MODIFIED:20220503T173820Z
UID:10000104-1656061200-1656066600@www.cannabisclinicians.org
SUMMARY:The SCC Quarterly Meeting: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics
DESCRIPTION:The Society of Cannabis Clinicians Quarterly Meeting Featuring Dr. Dustin Sulak \nFriday\, June 24\, 2022 \nEvent Description\n\nJoin us for the upcoming SCC Quarterly Meeting featuring Dr. Dustin Sulak as he shares his presentation on “Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics!” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nMeet Dr. Dustin Sulak: \nDr. Dustin Sulak \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/the-scc-quarterly-meeting-acidic-cannabinoids-inactive-precursors-or-powerful-therapeutics/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/05/unnamed.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20220520T084500
DTEND;TZID=Australia/Sydney:20220522T150000
DTSTAMP:20260603T233316
CREATED:20210423T112041Z
LAST-MODIFIED:20210906T124420Z
UID:10000079-1653036300-1653231600@www.cannabisclinicians.org
SUMMARY:Australian Medicinal Cannabis Symposium
DESCRIPTION:The United in Compassion Australian Medicinal Cannabis Symposium began as a patient led movement that changed the law and inspired a new industry for the benefit of Australian patients. Their focus remains on patients and helping them with better access by providing better education of the health workforce and promoting development of a viable\, professional and patient focused industry. \nPatients\, clinicians\, researchers and industry come together to examine exciting developments and to hear from renowned experts from home and from around the globe. \n  \nMORE INFO >>
URL:https://www.cannabisclinicians.org/event/united-in-compassion-australian-medicinal-cannabis-symposium/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/04/australia-cannabis-conference-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220506T090000
DTEND;TZID=America/Los_Angeles:20220506T093000
DTSTAMP:20260603T233316
CREATED:20220421T141840Z
LAST-MODIFIED:20220421T141840Z
UID:10000103-1651827600-1651829400@www.cannabisclinicians.org
SUMMARY:SCC & CSequence Presents Journal Club: "Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!"
DESCRIPTION:Friday\, May 6\, 2022 at 9am PDT / 12pm EDT \nResearch Presentation: SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!” \nSpeaker: Dr. Mihkail Kogan \nModerator: Zach Moore\, PhD \nEvent registration link: \nhttps://cannabisclinicians.tradewing.com/event/YsyEfdp5favrgo2r7 \nJoin us for an educational discussion with Mikhail Kogan\, MD as he highlights his recent research article “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.” \nLearn More About Mikhail Kogan: \n \nDr. Mikhail Kogan\, MD is a Medical Director\, GW Center for Integrative Medicine\, and the Assistant Professor\, George Washington University School of Medicine and Health Sciences. \nHe is an Integrative Medicine Fellowship Director\, Primary Care Internal Medicine\, Integrative Geriatrics\, Functional Medicine\, Integrative Palliative Care Physician. \nHe is also the founder and Executive Director of ex-officio\, of AIM Health Institute\, a 501 (c) (3) non-profit  organization \nDr. Kogan is a founding Board Member of the American Board of Integrative Medicine\, and a Board Member of the Art of Healing Foundation. \nDr Kogan is a leader in the newly-established field of Integrative Geriatrics. He is the chief editor of the first definitive textbook of the field entitled “Integrative Geriatric Medicine ”\, published by Oxford University Press as part of Andrew Weil Integrative Medicine Library series and is frequent speaker at a variety of international conferences on the topics of Integrative Medicine and Geriatrics\, healthy aging\, and geriatrics\, as well as neurodegenerative diseases\, and use of medical cannabis. Additionally\, he has published in both Integrative and Geriatric topics in leading US-based journals. \nDr. Kogan currently serves as medical director of the GW Center for Integrative Medicine and associate director of the Geriatrics Fellowship Program. He is the founder and director othe George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine\, as well as serving as part-time faculty member of the George Washington Institute for Spirituality and Health\, and the GW Center for Aging\, Health and Humanities. \nIn addition to his academic roles at George Washington University Dr. Kogan serves on a number of national boards and organizations including: the American Board of Integrative Medicine within the American Board of Physician Subspecialists (ABPS)\, ProCure Art\, PlantMed\, and others. Dr Kogan is also the founder and the chair of the board of AIM Health Institute\, a 501(c)(3) non-profit organization in the Washington\, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of their ability to pay. \nFor Dr. Mikhail Kogan\, the practice of medicine\, much like the rest of his life\, has been a journey spanning many miles and many cultures\, with valuable new learning and different perspectives accruing from each stage along the way. Those many experiences – here and abroad\, in the classroom and the clinic\, professionally and personally – have given Dr. Kogan the skills\, \, openness\, and inquisitiveness that set him apart\, and distinguish him as a committed and caring practitioner within integrative medicine. \nBorn in Moscow\, in the former Soviet Union\, Dr. Kogan emigrated with his family in his teens\, first to Israel\,and then to the United States\, where he obtained his medical degree from the Drexel University College of Medicine in Philadelphia\, Pennsylvania. He followed a Primary Care and Social Medicine Track residency in Internal Medicine at Montefiore Medical Center in New York City\, and a fellowship in Geriatric Medicine at the George Washington University Medical Center in Washington\, D.C.\, which led to a position as an assistant professor of medicine in the Division of Geriatrics and Palliative Care. \nIn addition to his training in conventional Western medicine\, Dr. Kogan has actively pursued a number of other healing arts and practices that have shaped his understanding of and approach to patient care. He is a graduate of a two-year training course in craniosacral therapy–a subtle osteopathic modality that has a wide range of effectiveness for different conditions such as headaches\, back pains\, and fatigue. He has also completed a four-year program at the Suluk Academy\, a teaching center based on the principles and traditions of Sufism\, where he learned how to incorporate meditation\, mindfulness\, and different spiritual practices into his daily life and his work with the patients. Among his many other areas of study are courses in Nutrition\, therapeutic use of vitamins\, Functional Medicine\, botanicals\, and other alternative modalities. \nWeaving those tools into the fabric of his medical practice has enabled Dr. Kogan to provide innovative and effective treatments to his patients with minimal use of invasive procedures or heavy reliance on medications and to understand the importance of self-exploration\, awareness and positive lifestyle changes as essential milestones on his patients’ journeys towards better health. Dr. Kogan is dedicated to helping patients with Alzheimer’s disease identify and correct underlying metabolic drivers work\, which is primarily based on Dr. Dale Bredesen’s research and newly created ReCode protocol. \nDr. Kogan practices Geriatric and Integrative Medicine in a variety of settings: at the George Washington Hospital\, at the GW Center for Integrative medicine\, as well as serving patients in home visits. \nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-csequence-presents-journal-club-cannabis-consumption-used-by-cancer-patients-during-immunotherapy-correlates-with-poor-clinical-outcome/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/04/Monthly-Journal-Club-May-with-Mikahil-Kogan.jpg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220415T110000
DTEND;TZID=America/Los_Angeles:20220415T123000
DTSTAMP:20260603T233316
CREATED:20220411T025604Z
LAST-MODIFIED:20220413T163300Z
UID:10000102-1650020400-1650025800@www.cannabisclinicians.org
SUMMARY:SCC & CSequence Journal Club Presents: "State Medical Cannabis Programs: What Physicians Should Know And Consider" Hosted By Richard Cheng\, JD\, CHC
DESCRIPTION:Friday\, April 15\, 2022 at 11am PDT / 2pm EDT\n\nResearch Presentation: “State Medical Cannabis Programs: What Physicians Should Know And Consider”\n\nSpeaker: Richard Cheng\, JD\, CHC \nModerator: Zach Moore\, PhD\n\nEvent registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed\nJoin us for a robust discussion with Richard Cheng\, JD\, CHC\, as we learn more about “State Cannabis Laws.” \n\nLearn More About Richard Cheng: \nRichard Cheng\, JD\, CHC \nRichard Cheng is a healthcare and cannabis regulatory and corporate attorney\, specializing in representing healthcare providers and cannabis businesses. He is also a healthcare professional holding a degree in Occupational Therapy (BSOT). \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-csequence-journal-club-presents-state-medical-cannabis-programs-what-physicians-should-know-and-consider-hosted-by-richard-cheng-jd-chc/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/04/Monthly-Journal-Club-with-Richard-Cheng-1.jpg
ORGANIZER;CN="SCC & CSequence":MAILTO:info@cannabisclincians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220408T090000
DTEND;TZID=America/Los_Angeles:20220408T090000
DTSTAMP:20260603T233316
CREATED:20220301T044704Z
LAST-MODIFIED:20220315T141155Z
UID:10000101-1649408400-1649408400@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Dr. Lauren Streicher\, "The Use of Cannabinoids in Menopause"
DESCRIPTION:Event Description\n\nJoin us for the upcoming SCC Quarterly Meeting featuring Dr. Lauren Streicher as she shares her presentation on “The Use of Cannabinoids in Menopause.” \nIf you are not an SCC member\, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member\, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member\, click here. \nLearn More About This Event:  \nThere are over 60 million menopause women in the United States\, and over 80% of those women experience debilitating  and life shortening symptoms such as hot flashes and insomnia. Only 7% get a prescription to relieve those symptoms since there is a persistent (and false) perception that estrogen is dangerous. Many post menopause women are turning to cannabis. Dr. Lauren Streicher\, a clinical professor of Obstetrics and Gynecology at the Feinberg School of Medicine\, Northwestern University\, and the Medical Director of the Northwestern Medicine Program for Menopause will discuss the potential role of cannabinoids in menopausal women. \nMeet Dr. Lauren Streicher: \n \nLauren Streicher\, MD is a clinical professor of obstetrics and gynecology at Northwestern University’s Feinberg School of Medicine\, and the medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner of the North American Menopause Society\, a member of the Sexual Medicine Society of North America\, Inc.\, The International Society for the Study of Women’s Sexual Health\, and The Scientific Network on Female Sexual Health and Cancer. In addition to authoring multiple scientific publications\, she has written multiple consumer books. Her most recent releases are Slip Sliding Away: Turning Back the Clock on Your Vagina and Hot Flash Hell: A Gynecologist’s Guide to Turning Down the Heat. \nDr. Streicher is the medical correspondent for Chicago’s top-rated news program\, the WGN Morning News\, and has appeared multiple times on The Today Show\, Good Morning America\, The Oprah Winfrey Show\, CNN\, NPR\, Dr. Radio\, Nightline\, Fox and Friends\, The Steve Harvey Show\, CBS This Morning\, ABC News Now\, NBC Nightly News\, 20/20\, and World News Tonight. She lives in Chicago with her writer-producer husband\, Jason Brett\, and their dog\, KJ. \n\nRegister to Attend
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-dr-lauren-streicher-the-use-of-cannabinoids-in-menopause/
LOCATION:Society of Cannabis Clinicians
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/02/Quarterly-meeting-with-Dr.-Streicher-IG-FB.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220314
DTEND;VALUE=DATE:20220316
DTSTAMP:20260603T233316
CREATED:20220114T022112Z
LAST-MODIFIED:20220114T030711Z
UID:10000099-1647216000-1647388799@www.cannabisclinicians.org
SUMMARY:CannX-Tel Aviv
DESCRIPTION:CannX Tel Aviv is the meeting point for global leaders in all areas of Medical Cannabis. First-hand knowledge and networks are essential in understanding the way forward within the complex ecosystem of medical cannabis. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists\, clinicians\, entrepreneurs\, investors\, policymakers\, and thought leaders for the ultimate opportunity to make an impact in the field. We haven’t had the chance to meet since 2020 due to the restrictions imposed by the Covid-19 pandemic and look forward to seeing you in person in Israel’s most cosmopolitan and vibrant city – Tel Aviv.
URL:https://www.cannabisclinicians.org/event/cannx-telaviv/
LOCATION:Tel Aviv\, Israel
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/01/CannX19-434-300x200-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220304T090000
DTEND;TZID=America/Los_Angeles:20220304T090000
DTSTAMP:20260603T233316
CREATED:20220208T221302Z
LAST-MODIFIED:20220301T211456Z
UID:10000100-1646384400-1646384400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Bonni Goldstein\, MD & Itzhak Kurek\, PhD - Cannabis-Responsive Biomarkers & Autism Spectrum Disorder
DESCRIPTION:March 4\, 2022 at 9am PST / 12pm EST\n\nArticle: Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.\n\nSpeakers: Bonni Goldstein\, MD & Itzhak Kurek\, PhD \nModerator: Zach Moore\, PhD\n\nEvent registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed\nJoin us for a robust discussion with Bonni Goldstein\, MD & Itzhak Kurek\, PhD moderated by Zach Moore\, PhD as we discover their newest publication\, “Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.” \nAutism spectrum disorder (ASD) is a group of neurodevelopmental conditions that impact behavior\, communication\, social interaction\, and learning abilities. Treatment of ASD with medical cannabis (MC) shows promising results in reducing the severity of certain behavioral aspects. The goals of this observational study are to demonstrate the potential of metabolic biomarkers to (1) objectively determine the impact on metabolites of MC treatment and (2) suggest the metabolic pathways of children with ASD\, who respond to MC treatment. \n\nLearn More About Dr. Bonni Goldstein: \nDr. Bonni Goldstein \nBonni Goldstein\, MD is the Medical Director of Canna-Centers Wellness & Education\, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions.  She completed her internship and residency at Children’s Hospital Los Angeles\, where she also served as chief resident.  After years of working in the specialty of Pediatric Emergency medicine\, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend.  Over the last 13 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics.  She has a special interest in treating children with intractable epilepsy\, autism\, cancer and other conditions. Her latest book\, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little\, Brown Spark. Dr. Goldstein recently co-authored a peer-reviewed article researching the use of Cannabis-Responsive biomarkers to document cannabis treatment efficacy\, guide clinical decision-making and improve outcomes. \n\nLearn More About Itzhak Kurek\, PhD: \nItzhak Kurek\, PhD \nItzhak Kurek\, PhD is the co-founder and CEO of Cannformatics\, Inc. a San Francisco-based biotechnology startup developing saliva-based Cannabis-Responsive™ biomarkers as a universal tool for the objective measurement of the physiological impact of any cannabinoid-based treatment. He has executive and research management experience in the Ag-Biotech\, Nutritional Supplements and Biobased Products businesses. Previously he held positions at Solix Algredients\, Kiverdi\, Pioneer Hi-Bred (DuPont) and Maxygen. He has published over 70 peer-reviewed scientific papers and patents. Dr. Kurek received his Ph.D. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California\, Davis. Dr. Kurek has also conducted research at the Technical University of Munich\, John Innes Center Norwich\, C.N.R.S Bordeaux and the Lawrence Berkeley National Laboratories. \n  \nREGISTER TO ATTEND
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-bonni-goldstein-md-itzhak-kurek-phd-cannabis-responsive-biomarkers-autism-spectrum-disorder/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2022/02/CannaTalk-with-Dr.-Goldstein-Kurek-IGFB.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220127
DTEND;VALUE=DATE:20220130
DTSTAMP:20260603T233317
CREATED:20220112T184549Z
LAST-MODIFIED:20220112T192920Z
UID:10000098-1643241600-1643500799@www.cannabisclinicians.org
SUMMARY:Cannabis Science & Industry Congress
DESCRIPTION:January 27-29\, 2022 | San Jose\, Costa Rica \nThe Cannabis Congress has partnered with the Society of Cannabis Clinicians to develop the Medical Track of the event featuring clinicians and researchers presenting the latest research and clinical findings on the therapeutic applications of cannabis. Doctors from Latin America\, the United States\, the EU\, and Canada will be addressing an array of the most sought-after clinical topics from pain\, sleep\, epilepsy\, mental health and more\, to clinician activism\, historical perspectives and indigenous knowledge of cannabis medicine. \n  \nMORE INFO >> \n  \n 
URL:https://www.cannabisclinicians.org/event/cannabis-science-industry-congress/
LOCATION:Parque Viva Main Gate\, Alajuela\, Costa Rica
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/12/cannabis-for-tic-disorders.png
ORGANIZER;CN="Cannabis Science and Industry Congress":MAILTO:info@thecannabiscongress.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220113T090000
DTEND;TZID=America/Los_Angeles:20220113T100000
DTSTAMP:20260603T233317
CREATED:20211207T103115Z
LAST-MODIFIED:20220112T181310Z
UID:10000097-1642064400-1642068000@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Dr. Josh Kaplan on CBD Exposure and Behavioral Changes in Mice
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Josh Kaplan discuss a paper on adolescent CBD exposure in mice not having substantive negative impacts on a range of behaviors in adulthood. It may also improve the rate of learning under certain conditions. \nPresenter:\nDr. Josh Kaplan \nArticle to be Discussed:\n\nCannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity\, Anxiety\, and Spatial Memory\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nDr. Josh Kaplan Josh Kaplan earned his Ph.D. in Behavioral Neuroscience in 2015 from Oregon Health & Science University and then joined the University of Washington for two postdoctoral fellowships where he trained in cannabinoid pharmacology. His work has contributed towards our understanding of the therapeutic potential of phytocannabinoids and the body’s endocannabinoid system. Dr. Kaplan’s research was instrumental in demonstrating the effectiveness of cannabidiol (CBD) as a monotherapy in treating medically-refractory seizures and improving autism-like social interaction deficits using pre-clinical genetic models of disease. Further\, he utilized his expertise in electrophysiology and pharmacological techniques to demonstrate a significant non-endocannabinoid mechanism-of-action by which CBD achieves its therapeutic relevance. His later studies focused on the therapeutic utility of enhancing endocannabinoid function and the relevant interactions with other inhibitory systems in the brain. \nDr. Kaplan is currently an Assistant Professor of Behavioral Neuroscience at Western Washington University in Bellingham\, WA\, where he trains undergraduate and graduate students in his cannabis research lab. By utilizing animal behavioral\, molecular\, pharmacological\, and electrophysiological techniques\, the Kaplan lab is working to identify ways of improving the plant’s therapeutic benefits and safety across a range of conditions. Their aim is to identify optimized cannabinoid and terpene compositions that extend the therapeutic dosing range while bolstering efficacy and limiting adverse effects. \nBeyond the lab\, Dr. Kaplan is a devoted mentor\, educator\, and science communicator. He has contributed numerous articles to peer reviewed journals\, book chapters\, as well as written for websites and magazines including High Times\, Cannabis and Tech Today\, and Leafly. He’s also spoken internationally on cannabis science for all types of audience and consulted for documentaries and popular science books. He was included in High Times’ 100 Most Influential People in Cannabis in 2018.
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dr-josh-kaplan/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/12/JournalClub-with-Dr.-Kaplan-Cseq-IgFb-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211216T090000
DTEND;TZID=America/Los_Angeles:20211216T103000
DTSTAMP:20260603T233317
CREATED:20211012T141021Z
LAST-MODIFIED:20211213T094652Z
UID:10000095-1639645200-1639650600@www.cannabisclinicians.org
SUMMARY:Cannabis & Psychedelics Webinar
DESCRIPTION:Join us for the inaugural Cannabis & Psychedelics Webinar put on by the Society of Cannabis Clinicians is co-hosting with the Psychedelic Medicine Association. \nThe event will focus on highlighting the psychedelic effects of cannabis and the therapeutic approaches of how cannabis can be used in conjunction with psychedelics (for example\, in between psychedelic-assisted therapy sessions to prolong the therapeutic benefits or within sessions to enhance effects\, etc.). The webinar will also focus on research on how psychedelics engage with the endocannabinoid system. The featured speakers will highlight their work in the field of psychedelic medicine to provide information on how clinicians can get training to utilize entheogens in their clinical practice. \nSpeakers & Topics: \n\nDustin Sulak\, DO: Beyond the Crutch and the Tonic: Cannabis as a Teacher\nSaj Razvi\, LPC: Cannabis & the Autonomic Nervous System: A Preferential Pathway for Psychedelic Therapy\nRebecca Kronman\, LCSW: Facing stigmas of medical cannabis and psychedelic-assisted therapies for clinicians and patients\nMark Braunstein\, DO\, ABPN: Psychiatric and medical considerations\, cannabis dosing as part of ketamine protocols\nMatthew Campeau\, LPC: Preventing and working with psychedelic crises\, thresholds and safety planning\n\nFurther info on each speaker can be found in their bio below. \nFree for SCC members\, $25 for non-members \n  \nRSVP >> \n  \nDustin Sulak\, D.O. is a traditional osteopathic physician and expert in integrative medicine. His clinical practice in Maine focuses on treating refractory conditions in adults and children. Dr. Sulak is an internationally-renowned expert in medical cannabis\, the author of the first foundational text on its clinical use\, Handbook of Cannabis for Clinicians: Principles and Practice\, and a co-founder of Healer.com\, a medical cannabis education resource. He is a passionate educator and leader in the field of medical cannabis\, and serves on the board of directors of The Society of Cannabis Clinicians. \n  \nSaj Razvi\, LPC is the founder and Director of Education at Psychedelic Somatic Institute. He was a clinical researcher in the MAPS Phase 2 trial of MDMA-assisted psychotherapy. He is faculty at Mind Medicine Australia and formerly taught PTSD studies at the University of Denver. He is the primary developer of the Psychedelic Somatic Interactional Psychotherapy (PSIP) modality which is a next generation non-ordinary state psychotherapy that maximizes the relational and autonomic healing capacity of psychedelic medicine to treat complex\, childhood developmental trauma. His primary focus is to train clinicians to provide legal\, effective psychedelic treatment in their private practice settings utilizing readily accessible medicines such as cannabis and ketamine. Click here to view an actual psychedelic therapy session using PSIP and cannabis. \n  \n  \n  \nRebecca Kronman\, LCSW is a licensed therapist and founder of Plant Parenthood\, a digital and in-person community of parents who use psychedelics. She is also an assisting trainer with Fluence\, a company that trains healthcare practitioners in harm reduction informed psychedelic preparation and integration. At her private practice in Brooklyn\, she works with clients using mindfulness\, experiential techniques and ketamine assisted psychotherapy to address depression\, anxiety and life transitions. She also helps clients prepare for psychedelic experiences\, incorporate insights or cope with challenges post-experience. Selected trainings include Mindfulness Based Stress Reduction\, Mindfulness for Clinicians\, Psychedelics 101 & 102 and Beyond Experience Psychedelic Integration Workshop. Outside of work\, she is a mother of two boys ages 5 and 7. \n  \n  \n  \nMark Braunstein\, DO\, ABPN Matthew trained as a psychotherapist at Naropa University in Transpersonal Counseling Psychology. He has been an Independent Rater with the Multidisciplinary Association for Psychedelic Studies (MAPS) since 2012\, currently supporting Phase 3 MDMA Assisted Psychotherapy studies. Matthew has trained in Ketamine Assisted Psychotherapy with the Ketamine Training Center. He has worked with thousands of suicidal and high acuity clients and is passionate about harm reduction and prevention. Matthew has 12 years clinical experience with individuals with mild to chronic and severe mental illnesses and has a strong ability to remain grounded and support clients in dysregulation\, crisis\, psychosis\, or altered states of consciousness. In addition to developing psychedelic psychotherapy protocols\, he practices ketamine and cannabis-assisted psychotherapy. \n  \n  \n  \n  \nMatthew Campeau\, LPC “Dr. B\,” is a whole health psychiatrist. He completed his residency in general psychiatry and his fellowship in child and adolescent psychiatry in 1997. Shortly thereafter\, he began exploring the use of psychoactive plant-based medicines in the treatment of various psychiatric conditions in both children and adults. With over 22 years of clinical experience\, Dr. B has pioneered a new path in psychiatric care that integrates wilderness programming\, exercise\, diet\, spirituality\, and natural medicines. Dr. B is the medical director for multiple mental health clinics\, including a groundbreaking psychedelic psychotherapy practice in Durango\, Colorado. His plant-based dosing protocols have made him a sought-after medical consultant\, advisor\, and educator. With a focus on expanding access\, awareness\, research\, and safety in the field of psychedelics\, Dr. B champions innovative technology and telemedicine at his company Reconscious Medical. His mission is to create tailored solutions that empower patients to live full\, happy\, unencumbered lives.
URL:https://www.cannabisclinicians.org/event/cannabis-psychedelics-webinar/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/10/Cannabis-Psychedelic-Medicine-Webinar-web-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211208T090000
DTEND;TZID=America/Los_Angeles:20211208T103000
DTSTAMP:20260603T233317
CREATED:20210929T135028Z
LAST-MODIFIED:20211206T085212Z
UID:10000094-1638954000-1638959400@www.cannabisclinicians.org
SUMMARY:SCC International Veterinary Alliance Webinar: Dosing & Administration
DESCRIPTION:9-10:30am PST / 11am-12:30pm CST / 12-1:30pm EST / 5-6:30pm BST  \nJoin an international lineup of experts exploring how veterinarians approach the philosophy of dosing and the main considerations when creating a treatment plan for animal patients. The SCC International Veterinary Alliance Webinar is open to anyone interested in the applications of cannabis in veterinary practice. \nTopic:\nCannabis Dosing and Administration Strategies in Veterinary Medicine \nSpeakers (bios below):\n\nSantiago Acosta\, DVM – (Colombia)\nRafael Ricardo Santisteban-Arenas\, DVM (Colombia)\nErik Almeida\, DVM (Brazil)\nTrina Hazzah\, DVM (USA)\nGary Richter\, DVM (USA)\nConny Mosley\, DVM (Canada)\nSarah Silcox\, DVM (Canada)\n\nFree for SCC members\, $10 for non-members \n  \nRSVP >> \n  \n Trina Hazzah\, DVM was born and raised in Washington DC. She attended Tuskegee University School of Veterinary Medicine where she earned her Doctor of Veterinary Medicine in 2006. She has also completed the requirements to be a Certified Veterinary Chinese Herbalist from the Chi Institute of Traditional Chinese Veterinary Medicine. Dr. Hazzah developed an interest in cannabis medicine during her quest for finding effective integrative approaches for veterinary cancer patients. She has spent the last half a decade reading through available literature\, attending multiple cannabis conferences and symposiums\, while also learning from cannabis physicians.  She is is the president and co-founder of the Veterinary Cannabis Society\, which is the first US-based non-profit\, 501(c)(3) organization building awareness of cannabis as medicine for pets. \n  \n  \n  \n  \nDr. Gary Richter has been practicing veterinary medicine in the SF Bay Area since 1998. He is certified in acupuncture\, chiropractic\, and Western herbology. Dr. Richter’s practice focuses on the benefits of conventional and holistic treatment methods for the preventative and therapeutic care of pets as well as educating professionals and pet owners on the benefits of integrative care. Dr. Richter was named Holistic Veterinarian of the Year for 2019 by the American Holistic Veterinary Medical Association\, is currently the President of the American College of Veterinary Botanical Medicine\, and is a founding member of the Veterinary Cannabis Society. \n  \n  \n  \n \n\nSantiago Acosta Colmenares\, DVM is the CEO of ENDOVET and the President of the Latin American Veterinary Medicine Association. He is currently a professor of medicinal cannabis at the National University of Colombia\, University of Rosario\, and University of Caldas. He is a member Society of Cannabis Clinicians (SCC) and Canadian Association of Veterinary Cannabinoid Medicine (CAVCM). He is also an advisor to the Colombian Agricultural Institute on issues related to medicinal cannabis in veterinary medicine. He is an international speaker on Medicinal Cannabis and entheogens in veterinary medicine and also designs cannabis-based products.\n \n \n \n \n \n \n  \n Dr. Sarah Silcox is a pioneer in the world of veterinary cannabis use and is one of the founding directors and the current President of the Canadian Association of Veterinary Cannabinoid Medicine. An OVC ‘97 grad\, she is a small animal veterinarian with over 20 years of clinical experience. Dr. Silcox has been active in general\, locum\, and emergency practice\, founded her region’s first integrative medicine practice\, and is currently operating her region’s first veterinary practice dedicated solely to palliative\, hospice\, and end-of-life care for pets. A passionate advocate for the veterinary use of cannabis and cannabinoid medicine\, her interest in the potential benefits of medical cannabis for pets reaches back several years. With changes in legislation that legalized cannabis in Canada\, she is grateful to now be able to guide her clients on the responsible use of cannabis for treating their pets and has seen numerous patients that have benefited from the therapeutic effects of this amazing plant.\n \n \n \n \n \nDr. Erik Amazonas is an Associated Professor of Veterinary Medicine at the Federal University of Santa Catarina. Dr. Amazonas was the first to include classes of endocannabinology in a veterinary school in Brazil in 2018. Dr. Erik collaborates with several universities and non profit organizations in Brazil and worldwide and is a member of the Veterinary Cannabis Society.\n \n \n \n  \n  \n \n  \n Dr. Cornelia (Conny) Mosley is a boarded anesthesiologist working as a Veterinary Consultant in Orthopedic Health and Pain for Elanco Canada as well as providing care for chronic pain patients in her Integrative Veterinary Pain Clinic at VCA Canada\, 404 Veterinary Emergency and Referral Hospital in Newmarket\, north of Toronto. She has a strong interest in pain management\, in particular in the integrative and collaborative approaches to pain relief. Conny is certified in veterinary acupuncture. Dr. Mosley is also the founding director and vice president of the Canadian Association of Veterinary Cannabinoid Medicine\, an organization that helps understand\, educate and collaborate in research in cannabinoid medicine and it’s role in veterinary medicine. \n  \n  \n Rafael Ricardo Santisteban-Arenas\, DVM is a DVM and MSc from Universidad de Caldas en Colombia. He is currently an Assistant Professor Institución Universitaria Visión de las Américas\, Pereira and Medical Coordinator Veterinary Clinic Institución Universitaria Visión de las Américas\, Pereira. He is also a Veterinary Advisor for Khiron Life Sciences Corp and Member of Red Cannabis Medicinal Veterinaria\, Colombia. His research publications include chronic gastrointestinal conditions\, cannabinoid therapy in small animals\, infectious diseases and palliative care.
URL:https://www.cannabisclinicians.org/event/scc-international-veterinary-alliance-webinar-dosing-administration/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/Veterinary-Alliance-Webinar-Banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211118T150000
DTEND;TZID=America/Los_Angeles:20211118T163000
DTSTAMP:20260603T233317
CREATED:20210929T082312Z
LAST-MODIFIED:20211020T162637Z
UID:10000092-1637247600-1637253000@www.cannabisclinicians.org
SUMMARY:Navigating The Complexities of Autism & Cannabis: Facts vs. Myths
DESCRIPTION:3-4:30pm PST\, 6-7:30pm EST \nThe SCC is hosting an event to highlight the complexities of autism and cannabis\, while dispelling fact vs. myth among this clinical research topic. \nThis free event on Thursday\, November 18th will serve as an educational resource for both clinicians and patients/caregivers as they explore the complexities and challenges associated with autism spectrum disorder and the use of medical cannabis. During the event\, our panelists will be sharing their clinical research insight\, while breaking down the facts versus myths surrounding ASD and medicinal cannabis. A Q&A session will also take place. Our speaker and panelist line up includes the following: \nFeatured Keynote Speaker– Patricia Frye\, MD\nHost: Sherry Yafai\, MD\nModerator: Minchul An\, PharmD \nPanelists: \n\nBonni Goldstein\, MD\nDustin Sulak\, DO\nDr. Muhsinah Morris\nMelani Kane\, PharmD\nGenesis A. Emery\n\nREGISTER >>
URL:https://www.cannabisclinicians.org/event/autism/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/SCC-Autism-Event-WEB-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Bogota:20211115T100000
DTEND;TZID=America/Bogota:20211121T170000
DTSTAMP:20260603T233317
CREATED:20211102T080949Z
LAST-MODIFIED:20211102T081032Z
UID:10000096-1636970400-1637514000@www.cannabisclinicians.org
SUMMARY:Vetcann On Line: Congreso Internacional De Cannabis Medicinal En Veterinaria
DESCRIPTION:Participa en el Congreso Anual: VETCANN 2021 Congreso Internacional de Cannabis en Medicina Veterinaria. \nNos complace hacerte parte de este encuentro de Educación\, Investigación y Desarrollo del Cannabis en Veterinaria por tercer año consecutivo\, de la mano de los mejores y con el apoyo de importantes entidades del gremio veterinario y del Cannabis en el mundo. \n\nMás de 30 conferencistas\n10 Salas temáticas\nMás de 10 países\n6 días de encuentro\n\nPara mayor información puedes hacer un preregistro en el siguiente link: \nRegistrarme >>
URL:https://www.cannabisclinicians.org/event/vetcann-on-line-congreso-internacional-de-cannabis-medicinal-en-veterinaria/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/11/cannabis-Veterinaria.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20211111T170000
DTEND;TZID=Europe/London:20211111T180000
DTSTAMP:20260603T233317
CREATED:20210920T155753Z
LAST-MODIFIED:20210921T134112Z
UID:10000090-1636650000-1636653600@www.cannabisclinicians.org
SUMMARY:Leading with Real-World Evidence: UK medical cannabis outcomes and global opportunities
DESCRIPTION:11th November 2021 – 9am PST\, 12pm EST\, 5pm GMT\, 18h CET \nThe Society of Cannabis Clinicians UK Chapter welcomes Sapphire Medical Clinics\, the UKs first and highest rated medical cannabis clinic\, to present “Leading with Real-World Evidence” on November 11th . Sharing the importance of Real-World Evidence in the global use of cannabis based medicines\, leading UK experts highlight what they’ve learnt so far\, and how to get involved. \nPart 1: The growth of Real-World Evidence in medical cannabis \nPart 2: Prescribing outcomes from the UK Medical Cannabis Registry \nPart 3: International collaboration opportunities \nRegister below for the free virtual event: Healthcare professionals and interested parties are welcome to join the 1 hour session. \nSpeakers\nDr. Mikael Sodergren is Managing Director and Academic Lead at Sapphire Medical Clinics\, the UK’s first and highest rated medical cannabis clinic. He is also an academic clinician and consultant hepatobiliary and pancreatic surgeon at Imperial College London\, where he leads a medical cannabis research programme. \nDr. Simon Erridge is Head of Research and Access at Sapphire Medical Clinics. Dr Erridge is also an honorary clinical research fellow at Imperial College London and junior doctor in North West London. \nDr. Ross Coomber is Operations Director at Sapphire Medical Clinics. As a Consultant Trauma and Orthopaedic Surgeon\, Dr Coomber completed a 12 month trauma fellowship in Canada where he first gained experience of working with medical cannabis. \nREGISTRATION >>
URL:https://www.cannabisclinicians.org/event/leading-with-real-world-evidence-uk-medical-cannabis-outcomes-and-global-opportunities/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/Sapphire-Institute-Society-of-Cannabis-banner-V2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211105T090000
DTEND;TZID=America/Los_Angeles:20211105T100000
DTSTAMP:20260603T233317
CREATED:20210908T161749Z
LAST-MODIFIED:20210909T090225Z
UID:10000088-1636102800-1636106400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Mariana Maciel\, MD on Water-soluble Nano-enhanced Cannabinoid Medicines
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Maciel discuss evidence about water-soluble nano-enhanced cannabinoid medicines and their applicability\, safety and how they differ from oil products. \nPresenter:\nMariana Maciel\, MD (bio below) \nTopic:\nWater-soluble Nano-enhanced Cannabinoid Medicines \nArticle to be Discussed:\n\nTowards Better Delivery of Cannabidiol (CBD)\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nMariana Maciel\, MD is a physician graduated at the Faculty of Medicine of Barbacena and completed her residency in Internal Medicine. She worked in Brazil in clinical ward\, urgency / emergency\, SAMU (paramedic)\, intensive care\, and family medicine. She worked with research\, article publishing and attended an internship at Charles University (CZ). She also has teaching experience at Universidade Federal de Viçosa. \nAlthough she was progressing in her medical career in Brazil\, Dr. Mariana chose to move to Canada in search of new opportunities and a better quality of life. In Canada\, in addition to getting married and becoming a mother\, she leveraged her career by specializing in Medicinal Cannabis and Cannabinoid Medicine. In Vancouver\, she is part of a Medicinal Cannabis clinic team. Her entrepreneurial profile added to her values of holistic and integral medicine which gave rise to Thronus Medical and Thronus Education. Dr. Mariana has put into practice her mission to transform and inspire people’s lives through medical education and the development of innovative cannabis-derived products.
URL:https://www.cannabisclinicians.org/event/journal-club-mariana-maciel-md-on-water-soluble-nano-enhanced-cannabinoid-medicines/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211014T090000
DTEND;TZID=America/Los_Angeles:20211014T100000
DTSTAMP:20260603T233317
CREATED:20210929T134028Z
LAST-MODIFIED:20211001T074250Z
UID:10000093-1634202000-1634205600@www.cannabisclinicians.org
SUMMARY:Legal Concerns for the Cannabis Healthcare Professional
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nWith cannabis remaining classified as a Schedule I drug under the federal Controlled Substances Act in the United States\, legal concerns for clinicians practicing cannabinoid medicine remain high. Join us for this informational session when SCC member Richard Cheng\, JD CHC will share what he has learned about the issues that healthcare professionals face when entering this clinical realm. \nThe SCC is excited to announce the alliance with INCBA (the International Cannabis Bar Association)\, a membership organization led by Christopher Davis. Their mission is to raise the standard of legal services available to the cannabis industry\, to advocate for the lawyers’ right to represent cannabis industry participants\, and to help build a solid foundation upon which the cannabis industry can sustainably thrive for years to come. Through our alliance\, SCC will serve as a resource to INCBA members providing research studies and medical expertise for clinical cases. Also INCBA members will address questions from SCC members facing legal issues and provide pro bono support when available. \nPresenters:\n  \nChristopher Davis\, Esq\nExecutive Director\, International Cannabis Bar Association\nPartnership announcement of SCC & INCBA; History and goals of INCBA \nRichard Cheng\, JD\, CHC\nHealthcare Attorney with Speciality in Cannabis \nTopics to be discussed:\nOverview of the current legal status for cannabis: \n\nHow cannabis is viewed by the public\nFederal and state prohibitions\nFederal protections\nPhysician concerns with cannabis\nLegal concerns and practices by facility based providers\nHealthcare fraud issues in cannabis\nAncillary concerns (e.g. contracts\, banking\, leases)\n\nFREE for SCC members. $10 for non members.  \n  \nREGISTRATION >>
URL:https://www.cannabisclinicians.org/event/legal-concerns-for-the-cannabis-healthcare-professional/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/pexels-photo-5668481.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211010T120000
DTEND;TZID=America/Los_Angeles:20211010T140000
DTSTAMP:20260603T233317
CREATED:20210924T085737Z
LAST-MODIFIED:20210928T095446Z
UID:10000091-1633867200-1633874400@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: The International Phytomedicine and Medical Cannabis Institute: High Impact Areas and Opportunities for Collaboration with Wilfred Ngwa\, MS\, PhD
DESCRIPTION:Join us for our quarterly meeting with featured speaker Wilfred Ngwa\, MS\, PhD. Dr. Ngwa will be discussing The International Phytomedicine and Medical Cannabis Institute: High impact areas and opportunities for collaboration with the USA. You may learn more about Dr. Ngwa’s work in the bio below. \nThe meeting is remote and free to all SCC members. Non members can also join for $10. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nWilfred Ngwa\, MS\, PhD has won 17 prestigious awards and honors over the past five years from Harvard\, the United States National Institutes of Health\, and international professional societies and organizations for his leading efforts in global health. His work has led to the establishment of new healthcare institutions and cancer centers in low and middle income countries. He has also trained thousands of healthcare professionals\, and established win-win collaborations for global health and economic development. He also is: \n\nDirector of the International Phytomedicine and Medical Cannabis Institute launched at Harvard in 2019\nA Distinguished Professor of Public Health ICT\nDirector of the Global Health Catalyst at Johns Hopkins and founding Director of the same program launched at Harvard Radcliffe institute in 2015 with afocus on catalyzing high impact collaborations for global health and development\nChair of the Lancet Oncology Commission for Sub-Saharan Africa\nFounder of the Global Oncology University\, an award-winning collaborative education model that offers everyone access to the same world class education and training available from professors at the world’s best institutions.\nCo-Director of the Africa-Oxford-Harvard (AfrOX-H) Clinical Trials network\nCurrently serves as Advisor for the USA government on Global Health
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-international-phytomedicine-and-medical-cannabis-institute-at-harvard-with-wilfred-ngwa/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/06/Quarterly-Meeting-website-banner.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20211001T090000
DTEND;TZID=America/Los_Angeles:20211001T100000
DTSTAMP:20260603T233317
CREATED:20210915T152032Z
LAST-MODIFIED:20210921T132607Z
UID:10000089-1633078800-1633082400@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: Dylan Zylla\, MD on Cannabis for Stage IV Cancer- Dosage\, Safety\, and Impact on Pain
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear from Dylan Zylla\, MD as he discusses the applications of cannabis for stage IV cancer\, dosing\, the impact on pain\, and patient safety. \nPresenter:\nDylan Zylla\, MD (bio below) \nTopic:\nA randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility\, dose requirements\, impact on pain and opioid use\, safety\, and overall patient satisfaction. \nArticle to be Discussed:\n\nA randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility\, dose requirements\, impact on pain and opioid use\, safety\, and overall patient satisfaction\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nDylan Zylla\, MD is a hematologist/oncologist working to answer key questions in clinical oncology and improve pain and symptom management among patients with cancer. He integrates research into his clinical practice with protected research time and access to an institution with a strong reputation in quantitative\, qualitative and clinical research. He is a site principal investigator on multiple industry-sponsored oncology clinical trials. His projects focus on cancer pain\, the mu-opioid receptor\, and novel ways to treat pain. He was a key member of the Minnesota Community Measurement’s work group that developed quality measures for cancer symptom control using patient-reported outcomes (PROs)\, and he collaborates with national leaders on integrating electronic PROs into cancer care. \nSince 2016\, Dr. Zylla has spearheaded large-scale efforts to address how cannabis impacts the lives of patients with cancer. He led the Cannabis in Cancer (CanCan) study which randomized patients with metastatic cancers to receive early vs delayed cannabis to treat symptoms. In 2018\, he published a survey of medical oncology professionals in Minnesota and demonstrated most clinicians support cannabis use for their patients. In collaboration with the Minnesota Department of Health\, he analyzed surveys of over 1\,000 patients with cancer\, certified in the state’s cannabis program since 2015. They found that those patients experienced significant clinical improvement in a variety of symptoms and reported few serious adverse events. \nRecently completed projects:\n• A randomized trial of cannabis in patients with stage IV cancers to assess dose requirements\, impact on pain and opioid use\, and overall patient satisfaction.\n• Impact of pain\, opioids\, and the mu-opioid receptor on progression and survival in patients with newly diagnosed stage IV pancreatic cancer. This project developed a novel immunohistochemical assay to determine the level of a mu-opioid receptor on a cancer cell. \nProjects in development include:\n• Cannabis registry on experience using cannabis\, including over-the-counter cannabidiol (CBD)\n• Topical cannabis/CBD creams for pain\n• Impact of medical cannabis for patients with newly diagnosed\, stage IV pancreas cancer\n• Cannabis as an anti-cancer agent\n• Mu-opioid receptor expansion project\n• Improving assessment and management of hyperglycemia in patients with diabetes and cancer
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dylan-zylla-on-cannabis-for-stage-iv-cancer-dosage-impact-on-pain-and-safety/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210923T090000
DTEND;TZID=America/Los_Angeles:20210923T100000
DTSTAMP:20260603T233317
CREATED:20210811T151340Z
LAST-MODIFIED:20210811T151340Z
UID:10000087-1632387600-1632391200@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis for Health Promotion & Disease Prevention with Dustin Sulak\, DO
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the September edition of “Canna Talk with Frye and Wilson-King” on September 23rd as we explore cannabis for health promotion and disease prevention with Dustin Sulak\, DO.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Sulak and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Sulak presented in his SCC Clinical Training Module Cannabis for Health Promotion & Disease Prevention. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \n \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-for-health-promotion-disease-prevention-with-dustin-sulak-md/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
END:VCALENDAR